Picture of Alimera Sciences logo

ALIM — Alimera Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Alimera Sciences Inc expected to post earnings of $1.06 a share - Earnings Preview

* Alimera Sciences Inc  ALIM.OQ   ALIM.O  is expected to show a
rise in quarterly revenue when it reports results on July 30
(estimated). 
* The Alpharetta, Georgia-based company is expected to report 
 a 59.8% increase in revenue to $16.04 million from $10.04
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Alimera Sciences Inc is
for earnings of $1.06 per share. For the same quarter last year,
the company reported a loss of 51 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Alimera
Sciences Inc is $16.25​, about 46.4% above​ its last closing
price of $8.71. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.52       -0.54      -0.63     Missed  -16.7
 Dec. 31 2020  -0.04       -0.04      -0.18     Missed  -315.4
 Sep. 30 2020  -0.44       -0.44      -0.12     Beat    72.9​
 Jun. 30 2020  -1.09       -1.61      -0.51     Beat    68.4
 Mar.          -0.44​      -0.43      -0.24     Beat    44.5​
 31​ 2020​                                              
 Dec. 31 2019  -0.35       -0.45      0.08      Beat    117.7​
 Sep. 30 2019  -0.57       -0.60      -0.60     Met     0
 Jun. 30 2019  -0.55       -0.55      -1.05     Missed  -90.9
 This summary was machine generated July 30 at 02:50 GMT.  All
figures in US dollars unless otherwise stated

Recent news on Alimera Sciences

See all news